Correlation between GEP and different single antigens in 52 DLBCL patients with available microarray data
| Antigen . | GEP . | |||
|---|---|---|---|---|
| No. of assessable patients . | GCB, n (%) . | ABC, n (%) . | ||
| CD10* | (−) (+) | 52 | 19 (47) 11 (92) | 21 (53) 1 (8) |
| BCL6 | (−) (+) | 48 | 12 (44) 15 (71) | 15 (56) 6 (36) |
| MUM1/IRF4† | (−) (+) | 49 | 22 (68) 6 (35) | 10 (32) 11 (65) |
| IRF8 | (−) (+) | 50 | 21 (64) 7 (41) | 12 (34) 10 (59) |
| GCET1 | (−) (+) | 48 | 12 (52) 16 (64) | 11 (48) 9 (36) |
| GCET2 | (−) (+) | 50 | 12 (55) 16 (57) | 10 (45) 12 (43) |
| FOXP1 | (−) (+) | 49 | 6 (86) 21 (50) | 1 (14) 21 (50) |
| LMO2 | (−) (+) | 48 | 10 (48) 18 (67) | 11 (52) 9 (33) |
| JAW1‡ | (−) (+) | 50 | 0 (0) 29 (63) | 4 (100) 17 (37) |
| BLIMP1 | (−) (+) | 49 | 14 (54) 15 (65) | 12 (46) 8 (35) |
| XBP1 | (−) (+) | 25 | 10 (63) 7 (78) | 6 (37) 2 (22) |
| BCL2 | (−) (+) | 51 | 20 (67) 9 (43) | 10 (33) 12 (21) |
| Antigen . | GEP . | |||
|---|---|---|---|---|
| No. of assessable patients . | GCB, n (%) . | ABC, n (%) . | ||
| CD10* | (−) (+) | 52 | 19 (47) 11 (92) | 21 (53) 1 (8) |
| BCL6 | (−) (+) | 48 | 12 (44) 15 (71) | 15 (56) 6 (36) |
| MUM1/IRF4† | (−) (+) | 49 | 22 (68) 6 (35) | 10 (32) 11 (65) |
| IRF8 | (−) (+) | 50 | 21 (64) 7 (41) | 12 (34) 10 (59) |
| GCET1 | (−) (+) | 48 | 12 (52) 16 (64) | 11 (48) 9 (36) |
| GCET2 | (−) (+) | 50 | 12 (55) 16 (57) | 10 (45) 12 (43) |
| FOXP1 | (−) (+) | 49 | 6 (86) 21 (50) | 1 (14) 21 (50) |
| LMO2 | (−) (+) | 48 | 10 (48) 18 (67) | 11 (52) 9 (33) |
| JAW1‡ | (−) (+) | 50 | 0 (0) 29 (63) | 4 (100) 17 (37) |
| BLIMP1 | (−) (+) | 49 | 14 (54) 15 (65) | 12 (46) 8 (35) |
| XBP1 | (−) (+) | 25 | 10 (63) 7 (78) | 6 (37) 2 (22) |
| BCL2 | (−) (+) | 51 | 20 (67) 9 (43) | 10 (33) 12 (21) |